Streamlining Research on Controlled Substances Act of 2021 2021-04-08 Introduced in House Streamlining Research on Controlled Substances Act of 2021

This bill makes changes to the registration process for conducting research on controlled substances that are included in schedule I of the Controlled Substances Act.

Among the changes, the bill does the following:

  • exempts from the registration requirements an agent or employee of a registered researcher,
  • permits a single registration for contiguous research sites, and
  • requires the Drug Enforcement Administration and the Department of Health and Human Services to review and issue guidance on the processes to obtain or modify federal authorization to conduct research with controlled substances.
]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.